ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,203,256 | -7.0% | 39,143 | +9.0% | 0.01% | -28.6% |
| Q1 2023 | $1,294,270 | +182.8% | 35,922 | +210.2% | 0.01% | +250.0% |
| Q4 2022 | $457,721 | -76.5% | 11,582 | -76.1% | 0.00% | -77.8% |
| Q3 2022 | $1,950,000 | +8025.0% | 48,525 | +8266.4% | 0.01% | – |
| Q2 2022 | $24,000 | -89.3% | 580 | -89.9% | 0.00% | -100.0% |
| Q1 2022 | $224,000 | +622.6% | 5,759 | +644.1% | 0.00% | – |
| Q4 2021 | $31,000 | -99.4% | 774 | -99.4% | 0.00% | -100.0% |
| Q3 2021 | $4,881,000 | -57.7% | 135,049 | -52.1% | 0.01% | -52.0% |
| Q2 2021 | $11,550,000 | +5247.2% | 281,774 | +5598.2% | 0.02% | +2400.0% |
| Q1 2021 | $216,000 | -77.8% | 4,945 | -75.3% | 0.00% | -87.5% |
| Q2 2020 | $971,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |